Human Aryl Hydrocarbon Receptor Polymorphisms That Result in Loss of CYP1A1 Induction
- 1 November 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 288 (4), 990-996
- https://doi.org/10.1006/bbrc.2001.5861
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interactions of Nuclear Receptor Coactivator/Corepressor Proteins with the Aryl Hydrocarbon Receptor ComplexArchives of Biochemistry and Biophysics, 1999
- The AH Receptor and a Novel Gene Determine Acute Toxic Responses to TCDD: Segregation of the Resistant Alleles to Different Rat LinesToxicology and Applied Pharmacology, 1999
- FUNCTIONS AND TRANSCRIPTIONAL REGULATION OF PAH-INDUCIBLE HUMAN UDP-GLUCURONOSYL-TRANSFERASESDrug Metabolism Reviews, 1999
- Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cellsBiochemical Pharmacology, 1998
- Activation of Heterocyclic Aromatic Amines by Rat and Human Liver Microsomes and by Purified Rat and Human Cytochrome P450 1A2Chemical Research in Toxicology, 1998
- Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibilityPharmacogenetics, 1995
- Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 micePharmacogenetics, 1993
- In vitro analysis of Ah receptor domains involved in ligand-activated DNA recognition.Proceedings of the National Academy of Sciences, 1993
- The Ah Locus: Genetic Differences in Toxicity, Cancer, Mutation, and Birth DefectsCritical Reviews in Toxicology, 1989
- Tumour promotion by TCDD in skin of HRS/J hairless miceNature, 1982